Treatment of High-Grade Non-Muscle Invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations versus Reduced Number and Standard Dose of BCG Instillations. Results of the European Association of Urology Research Foundation Phase III Clinical Trial ‘NIMBUS’.

14 October 2020

Share this on your favourite network: